Skip to main content
NIH funding notice RFA-DA-22-007

Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed)

Closed on October 14, 2021.

Posted
May 24, 2021
Close date
October 14, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $982,868 in first-year total cost, median $491,434.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 LXF-C (06)]2

Most frequent institutions

  1. TEMPLE UNIV OF THE COMMONWEALTH1
  2. UNIVERSITY OF MINNESOTA1
Competing awards under RFA-DA-22-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Delineating the epigenetic and neural mechanisms by which early life scarcity alters motivated behavior1R01DA056534-01BANGASSER, DEBRA AWIMMER, MATHIEUTEMPLE UNIV OF THE COMMONWEALTH, PA$643,242ZDA1
2022Neurobehavioral mechanisms linking childhood social disadvantage with substance use trajectories in adolescence and adulthood1R01DA056499-01WILSON, SYLIAUNIVERSITY OF MINNESOTA, MN$339,626ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-22-007: Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience